Barclays
ISPC icon

Barclays’s iSpecimen ISPC Stock Holding History

Barclays’s Portfolio ISPC Stock Details ISPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2 Buy
+2
New +$4 ﹤0.01% 5312

Other funds holding ISPC

StoneX Group
StoneX Group New York $2.75B AUM 24.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Barclays's ISPC Position: Q3 2026 in Review

Barclays opened a new position in iSpecimen (ISPC) in Q3 2026: 2 shares worth $2. The stake represents ﹤0.01% of the portfolio and ranks #5312 among its holdings.

5 funds tracked by Wall St. Rank hold ISPC as of Q3 2026.

  • Barclays held 2 shares of iSpecimen worth $2 as of Q3 2026.
  • iSpecimen was a new Barclays position in Q3 2026.
  • iSpecimen made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5312 holding.
  • 5 funds tracked by Wall St. Rank held iSpecimen as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.